Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Affect Disord ; 359: 308-318, 2024 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-38795780

RESUMO

BACKGROUND: Generalized anxiety disorder (GAD) is the least successfully treated anxiety disorder. This clinical trial investigated the effects and efficacy of a novel self-compassion intervention in GAD. METHODS: A total of 75 GAD patients were assigned to a self-compassion intervention group (n = 25), a mindfulness intervention group (n = 25), or a treat-as-usual group (n = 25). Patients in the two active groups received eight intervention sessions in two weeks in addition to usual treatment i.e., pharmacotherapy. Primary outcomes were anxiety and worry, assessed at pre-intervention, post-intervention, and three-month follow-up. Secondary outcomes included depression, sleep, as well as self-compassion and mindfulness. RESULTS: Both the self-compassion and mindfulness intervention induced a more rapid decrease in anxiety and depression than pharmacological treatment alone with excellent response and remission rate. Self-compassion intervention also induced a more rapid improvement in sleep quality compared to mindfulness intervention and pharmacological treatment alone. We also presented a mechanism for the self-compassion intervention in which decreased anxiety led to improvement in sleep quality. There was also a higher pleasure, acceptance, and willingness to re-attend in the self-compassion compared to the mindfulness intervention. LIMITATIONS: This study was single blinded and nonrandomized which may bring risks of bias. CONCLUSIONS: Overall, we provided novel evidence that self-compassion intervention is an alternative psychotherapy for GAD with excellent response and acceptability.


Assuntos
Transtornos de Ansiedade , Empatia , Atenção Plena , Humanos , Feminino , Transtornos de Ansiedade/terapia , Masculino , Adulto , Atenção Plena/métodos , Pessoa de Meia-Idade , Resultado do Tratamento , Depressão/terapia , Autoimagem , Qualidade do Sono
2.
Luminescence ; 39(5): e4743, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38692854

RESUMO

A unique luminescent lanthanide metal-organic framework (LnMOF)-based fluorescence detection platform was utilized to achieve sensitive detection of vomitoxin (VT) and oxytetracycline hydrochloride (OTC-HCL) without the use of antibodies or biomolecular modifications. The sensor had a fluorescence quenching constant of 9.74 × 106 M-1 and a low detection limit of 0.68 nM for vomitoxin. Notably, this is the first example of a Tb-MOF sensor for fluorescence detection of vomitoxin. We further investigated its response to two mycotoxins, aflatoxin B1 and ochratoxin A, and found that their Stern-Volmer fluorescence quenching constants were lower than those of VT. In addition, the fluorescence sensor realized sensitive detection of OTC-HCL with a detection limit of 0.039 µM. In conclusion, the method has great potential as a sensitive and simple technique to detect VT and OTC-HCL in water.


Assuntos
Estruturas Metalorgânicas , Oxitetraciclina , Térbio , Oxitetraciclina/análise , Oxitetraciclina/química , Térbio/química , Estruturas Metalorgânicas/química , Espectrometria de Fluorescência , Corantes Fluorescentes/química , Limite de Detecção , Água/química , Fluorescência , Poluentes Químicos da Água/análise
3.
J Orthop Surg Res ; 18(1): 215, 2023 Mar 19.
Artigo em Inglês | MEDLINE | ID: mdl-36935491

RESUMO

PURPOSE: To investigate the clinical efficacy and advantages of the SuperPath approach for total hip arthroplasty in the treatment of femoral neck fractures in the elderly population. METHODS: From February 2018 to March 2019, 120 patients were randomly divided into two groups with 60 patients each: the SuperPath group and the conventional group. The results evaluated included the general operation situation, serum markers, blood loss, pain score, hip function and prosthesis location analysis. RESULTS: There was no demographic difference between the two groups. Compared with the conventional group, the SuperPath group had a shorter operation time (78.4 vs. 93.0 min, p = 0.000), a smaller incision length (5.8 vs. 12.5 cm, p = 0.000), less intraoperative blood loss (121.5 vs. 178.8 ml, p = 0.000), a shorter hospitalization time (8.0 vs. 10.8 days, p = 0.000) and less drainage volume (77.8 vs. 141.2 ml, p = 0.000). The creatine kinase level in the SuperPath group was significantly lower than that in the conventional group, while there was no difference in the C-reactive protein level and erythrocyte sedimentation rate level. The visual analog scale score was lower one month postoperatively, and the Harris hip score was higher three months postoperatively in the SuperPath group (p < 0.05). There was no difference in the cup abduction angle or anteversion angle of the two groups. CONCLUSION: We found better clinical efficacy after using the SuperPath approach with less muscle damage, less postoperative pain and better postoperative function than after using the modified Hardinge approach. Trial registration The randomized clinical trial was retrospectively registered at the Chinese Clinical Trial Registry on 31/12/2020 (ChiCTR-2000041583, http://www.chictr.org.cn/showproj.aspx?proj=57008 ).


Assuntos
Artroplastia de Quadril , Fraturas do Colo Femoral , Humanos , Idoso , Artroplastia de Quadril/métodos , Resultado do Tratamento , Dor Pós-Operatória/etiologia , Dor Pós-Operatória/prevenção & controle , Dor Pós-Operatória/cirurgia , Perda Sanguínea Cirúrgica/prevenção & controle , Fraturas do Colo Femoral/cirurgia
4.
Luminescence ; 38(5): 609-612, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-36918408

RESUMO

Tryptophan is one of important amino acids in the human body, therefore its detection is particularly important. The 3,5-bis(4-pyridyl)-4-amino-1,2,4-triazole (BPAT) organic molecule was designed to be used as fluorescence detectors to detect tryptophan molecules for the interaction between the host and the guest. BPAT shows good sensitivity and selectivity towards tryptophan compared with other amino acid molecules. The limit of detection obtained from formula 3δ/KSV is considered to be 5.43 × 10-7  mol/L. We speculated that this change is mainly caused by the hydrogen bond between tryptophan and the host molecule BPAT. This conjecture was verified by the controlled experiments with other host molecules.


Assuntos
Aminoácidos , Triptofano , Humanos , Triptofano/química , Ligação de Hidrogênio , Espectrometria de Fluorescência
5.
Brain Inj ; 35(11): 1457-1461, 2021 09 19.
Artigo em Inglês | MEDLINE | ID: mdl-34702117

RESUMO

OBJECTIVES: Serum ischemia-modified albumin (IMA) is higher in patients with cerebral infarction (CI). In this study, we aimed at studying the association between IMA and CI. METHODS: Patients with CI were divided to severe stenosis group and mild stenosis group according to the stenosis of vertebrobasilar artery. Digital subtraction angiography (DSA) and magnetic resonance imaging (MRI) were used for diagnosis. Cobalt-combined with Albumin test was used to determine the serum IMA levels. Serum IMA levels in patients with CI and healthy volunteers were compared by t test. Receiver operating characteristic (ROC) curve was performed for evaluating the diagnostic efficiency of serum IMA for CI. The correlation between IMA level and the National Institute of Health Stroke Scale(NIHSS) score after treatment was analyzed. RESULTS: Serum IMA levels in patients with CI was increased compared to healthy volunteers(P < .05). Patients in severe stenosis group had a higher serum IMA level than mild stenosis group(P < .05). Serum IMA level at admission was associated with NIHSS score on the 7th day after treatment(P < .05). CONCLUSIONS: Serum IMA level was correlated with vertebrobasilar artery stenosis and  short-term prognosis in patients with acute CI.


Assuntos
Albumina Sérica , Insuficiência Vertebrobasilar , Biomarcadores , Infarto Cerebral/diagnóstico por imagem , Constrição Patológica , Humanos , Albumina Sérica Humana , Insuficiência Vertebrobasilar/diagnóstico por imagem
6.
Front Psychiatry ; 11: 537981, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33192653

RESUMO

Abnormity in brain regional function and inter-regional cooperation have been linked with the dysfunction during cognitive and emotional processing in bipolar disorder (BD) patients. Recent evidences have suggested that brain function is not static but temporal dynamic. In present study, we aimed to characterize the temporal dynamics of regional function and inter-regional cooperation in BD and its relationship with executive dysfunction, an important deficit in BD. Resting-state functional MRI was performed in patients with bipolar I disorder (BDI) (n = 18) and healthy controls (HCs, n = 19). We first assessed local-function temporal variety with dynamic amplitude of low-frequency fluctuation (dALFF). Region with significant inter-groups difference in dALFF was chosen as a seed to calculate inter-regions connective temporal variety with dynamic functional connectivity (dFC). The executive function was measured by Verbal Fluency Test (VFT). The relationship between executive function and brain dynamics were examined. Compared with HC, the BDI group showed decreased dALFF (less temporal variability) in the posterior cingulate cortex (PCC) and decreased dFC between PCC and medial prefrontal cortex (mPFC). The PCC-mPFC dFC was positively associated with VFT in BDI patients, but not in HC. These findings implicated the reduced temporal variability in local region and inter-regions cooperation in BDI, which may be a neural substrate of executive-function deficit in BDI.

7.
Med Sci Monit ; 24: 5894, 2018 08 24.
Artigo em Inglês | MEDLINE | ID: mdl-30139930

RESUMO

This paper is being retracted based on publishers' legal criteria. We have received notification from the author, Yonghui Shen, that he had added Dr. Wei Zhang (the first author) as a co-author fraudulently, without his permission or authorization, and that he falsified the confirmation from Dr. Zhang. Dr. Wei Zhang had no contribution to this paper.

8.
Med Sci Monit ; 24: 5178-5184, 2018 Jul 26.
Artigo em Inglês | MEDLINE | ID: mdl-30046030

RESUMO

BACKGROUND We studied the expression and effect of miR-26a-5p in synovial fibroblast in patients with rheumatoid arthritis (RA). MATERIAL AND METHODS The synovial tissues of 55 RA patients with total knee arthroplasty performed from January 2016 to December 2016 were collected as the RA group, and 62 patients without RA history amputation or total knee arthroplasty served as the control group. The expressions of miR-26a-5p and Smad 1 mRNA in synovial fibroblast in patients with RA were detected by qPCR; The expression of Smad 1 and TGF-ß1 protein in synovial tissue or synovial fibroblasts was detected by immunoblotting. Transwell assay was used to detect the invasive ability of synovial fibroblasts. RESULTS The expression of miR-26a-5p and Smad 1 in synovial fibroblast in patients with RA were significantly higher than those in the control group (P<0.05). The expression of miR-26a-5p in synovial tissue of RA patients was positively correlated with the expression of Smad 1 mRNA (r=0.8982, P<0.001). The luciferase system showed that miR-26a-5p targeting synovial membrane FLS cells (P<0.05); the expression of MMP-1, MMP-3, MMP-13, and TGF-b1 protein and mRNA in the synovial FLS cells of RA patients was significantly decreased; and the expression of miR-26a-5p was significantly decreased in FLS cells with invasive ability. CONCLUSIONS miR-26a-5p is highly expressed in synovial tissue of patients with RA, and its high expression can improve the invasive ability of synovial fibroblasts by targeting Smad 1 gene and accelerating the progression of RA.


Assuntos
Artrite Reumatoide/genética , MicroRNAs/biossíntese , Proteína Smad1/metabolismo , Membrana Sinovial/metabolismo , Adulto , Idoso , Artrite Reumatoide/metabolismo , Artrite Reumatoide/patologia , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Progressão da Doença , Feminino , Fibroblastos/metabolismo , Fibroblastos/patologia , Regulação da Expressão Gênica , Humanos , Masculino , Metaloproteinases da Matriz/metabolismo , MicroRNAs/genética , MicroRNAs/metabolismo , Pessoa de Meia-Idade , Proteína Smad1/biossíntese , Proteína Smad1/genética , Membrana Sinovial/patologia , Fator de Crescimento Transformador beta1/biossíntese , Fator de Crescimento Transformador beta1/genética
9.
Med Sci Monit ; 20: 1461-8, 2014 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-25129549

RESUMO

BACKGROUND: The aim of this study was to investigate the influence of carotid artery stenting (CAS) on the cognition and quality of life of elderly patients with severe stenosis of the internal carotid artery. MATERIAL/METHODS: 65 elderly patients with symptomatic severe stenosis of internal carotid artery were recruited into 2 groups: the pharmacotherapy group (n=29) and the CAS group (n=36). Before surgery and 1, 3, 6, and 12 months after surgery, Montreal cognitive assessment (MoCA) was used for the evaluation of cognition and WHOQOL-BREF was used for the assessment of quality of life. RESULTS: At 12 months after surgery, total MoCA score and WHOQOL-BREF score in the pharmacotherapy group was significantly reduced when compared with those before surgery (P<0.05). In the CAS group, the total MoCA score, scores of attention and delayed recall, and WHOQOL-BREF score increased significantly at different time points after surgery when compared with those before surgery (P<0.05). Moreover, in CAS group, the MoCA score and WHOQOL-BREF markedly increased gradually over time (P<0.05). Compared with the pharmacotherapy group, cognition and quality of life in the CAS group were improved dramatically during the follow-up period (P<0.05). CONCLUSIONS: Severe stenosis of the internal carotid artery is a cause of cognition impairment, and CAS may improve cognition and quality of life.


Assuntos
Angioplastia/efeitos adversos , Estenose das Carótidas/tratamento farmacológico , Estenose das Carótidas/cirurgia , Cognição/fisiologia , Qualidade de Vida/psicologia , Stents , Idoso , Análise de Variância , Aspirina/uso terapêutico , Atorvastatina , China , Clopidogrel , Feminino , Ácidos Heptanoicos/uso terapêutico , Humanos , Masculino , Pirróis/uso terapêutico , Fluxo Sanguíneo Regional/fisiologia , Ticlopidina/análogos & derivados , Ticlopidina/uso terapêutico , Resultado do Tratamento , Ultrassonografia Doppler Transcraniana
10.
Med Sci Monit ; 20: 1129-36, 2014 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-24990175

RESUMO

BACKGROUND: We aimed to investigate cognitive function and affective disorder in elderly patients with symptomatic vertebrobasilar artery stenosis (SVAS) after stent-assisted angioplasty (SAA) and to explore the potential mechanism. MATERIAL AND METHODS: The study subjects were 26 elderly SVAS patients who were non-responsive to pharmacotherapy and received SAA (study group) and 30 patients receiving intracoronary stent implantation (control group). Montreal cognitive assessment (MoCA), Hamilton depression rating scale (HAMD), and Hamilton anxiety rating scale (HAMA) were used. RESULTS: The total MoCA score, scores of line connection, copying cube, drawing clock, and delayed recall increased significantly in the study group after surgery (P<0.05, P<0.01). In addition, the MoCA score increased over time and the total MoCA score at 12 months was markedly higher than that at 1 month (P<0.05). The scores of HAMD and HAMA decreased dramatically after surgery compared with before surgery in these patients (P<0.01). A comparison at the corresponding period was performed between study group and control group, and it was found that the differences in total MoCA scores and scores of line connection, copying cube, drawing clock, and delayed recall before surgery and at 1 month after surgery were significant (P<0.05, P<0.01). CONCLUSIONS: SAA may improve the visuospatial/executive abilities and delayed recall, as well as the depression and anxiety in patients with SVAS. Larger and controlled trails are needed to investigate the effect of SAA on cognition and affection in these patients.


Assuntos
Angioplastia , Arteriopatias Oclusivas/terapia , Artéria Basilar/fisiopatologia , Cognição/fisiologia , Transtornos do Humor/fisiopatologia , Stents , Artéria Vertebral/fisiopatologia , Idoso , Angioplastia/efeitos adversos , Arteriopatias Oclusivas/fisiopatologia , Artéria Basilar/patologia , Velocidade do Fluxo Sanguíneo , Estudos de Casos e Controles , Constrição Patológica , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Complicações Pós-Operatórias/etiologia , Recidiva , Fluxo Sanguíneo Regional , Stents/efeitos adversos , Acidente Vascular Cerebral/etiologia , Artéria Vertebral/patologia
11.
Zhongguo Zhong Yao Za Zhi ; 37(23): 3667-8, 2012 Dec.
Artigo em Chinês | MEDLINE | ID: mdl-23477161

RESUMO

OBJECTIVE: To observe the clinical efficacy of Maixuekang capsule in reconvalescents of cerebral infarction and its impact on coagulation function. METHOD: One hundred and twenty cases of reconvalescents of cerebral infarction were randomly divided into treatment and control groups. The 50 cases in the control group were provided with conventional therapy, while the 70 cases in the treatment group were provided with the combination of conventional therapy and Maixuekang capsule for 3 months. Their neurological function and prothrombin time (PT), activated partial thromboplastin time (APTT) clotting enzyme time (TT), fibrinogen (Fib) were measured before and after treatment. RESULT: After the treatment, PT, APTT and TT were prolonged compared with those before the treatment in the treatment group (P<0.05), whereas Fib, neurological deficit scores decreased (P<0.01) and significantly different from the control group (P<0.05). CONCLUSION: Maixuekang capsule is among safe and effective drugs in treatment of reconvalescents of cerebral infarction, and can improve the patient's coagulation state.


Assuntos
Infarto Cerebral/tratamento farmacológico , Medicamentos de Ervas Chinesas/administração & dosagem , Idoso , Coagulação Sanguínea/efeitos dos fármacos , Cápsulas/uso terapêutico , Infarto Cerebral/metabolismo , Infarto Cerebral/fisiopatologia , Medicamentos de Ervas Chinesas/efeitos adversos , Feminino , Fibrinogênio/metabolismo , Humanos , Masculino , Tempo de Protrombina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...